Place in therapy of innovative drugs in multiple myeloma in 2021 and 2023 according to an expert panel Delphi consensus

INTRODUCTION: The objective of this study was to understand the potential use of single agents and drug combinations in multiple myeloma (MM) across treatment lines in the years 2021 and 2023. METHODS: The method used was Delphi Panel Method survey, administered to European Myeloma Network (EMN) Ita...

Descripción completa

Detalles Bibliográficos
Autores principales: Mario, Boccadoro, Patrizia, Berto, Sara, Bringhen, Elena, Zamagni, Patrizia, Tosi, Nicola, Cascavilla, Nicola, Giuliani, Donato, Mannina, Renato, Zambello, Francesca, Patriarca, Vittorio, Montefusco, Mariella, Grasso, Francesco, Di Raimondo, Massimo, Offidani, Teresa, Petrucci Maria, Pellegrino, Musto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AboutScience 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616197/
https://www.ncbi.nlm.nih.gov/pubmed/36627863
http://dx.doi.org/10.33393/grhta.2021.2245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616197/
https://www.ncbi.nlm.nih.gov/pubmed/36627863
http://dx.doi.org/10.33393/grhta.2021.2245

Ejemplares similares